$628 Million is the total value of Ikarian Capital, LLC's 122 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 86.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | ACELYRIN INC | $60,995,103 | – | 2,918,426 | +100.0% | 9.71% | – | |
| ARGX | New | ARGENX SEput | $51,483,333 | – | 132,100 | +100.0% | 8.20% | – |
| BBIO | Buy | BRIDGEBIO PHARMA INCcall | $21,152,560 | +132.1% | 1,229,800 | +123.8% | 3.37% | +62.9% |
| BMEA | Buy | BIOMEA FUSION INCcall | $20,562,760 | +127.9% | 936,800 | +221.9% | 3.28% | +60.0% |
| TGTX | New | TG THERAPEUTICS INCput | $20,520,324 | – | 826,100 | +100.0% | 3.27% | – |
| TGTX | New | TG THERAPEUTICS INCcall | $20,520,324 | – | 826,100 | +100.0% | 3.27% | – |
| AZN | New | ASTRAZENECA PLCcall | $17,892,500 | – | 250,000 | +100.0% | 2.85% | – |
| ARGX | New | ARGENX SEcall | $14,809,740 | – | 38,000 | +100.0% | 2.36% | – |
| SRPT | Sell | SAREPTA THERAPEUTICS INCput | $13,982,892 | -62.6% | 122,100 | -55.0% | 2.23% | -73.8% |
| New | VENTYX BIOSCIENCES INCput | $12,270,480 | – | 374,100 | +100.0% | 1.95% | – | |
| APLS | Buy | APELLIS PHARMACEUTICALS INC | $12,189,180 | +84.8% | 133,800 | +33.8% | 1.94% | +29.7% |
| APLS | New | APELLIS PHARMACEUTICALS INCput | $12,116,300 | – | 133,000 | +100.0% | 1.93% | – |
| MRK | MERCK & CO INC | $11,538,999 | +8.5% | 100,000 | 0.0% | 1.84% | -23.9% | |
| IDYA | New | IDEAYA BIOSCIENCES INC | $11,535,987 | – | 490,893 | +100.0% | 1.84% | – |
| New | NUVALENT INC | $11,501,952 | – | 272,752 | +100.0% | 1.83% | – | |
| CRSP | New | CRISPR THERAPEUTICS AGput | $11,228,000 | – | 200,000 | +100.0% | 1.79% | – |
| CRSP | New | CRISPR THERAPEUTICS AGcall | $11,228,000 | – | 200,000 | +100.0% | 1.79% | – |
| RETA | Buy | REATA PHARMACEUTICALS INCcall | $11,215,600 | +23.4% | 110,000 | +10.0% | 1.79% | -13.4% |
| New | DISC MEDICINE INC | $10,657,376 | – | 240,031 | +100.0% | 1.70% | – | |
| INSM | INSMED INC | $10,233,500 | +23.8% | 485,000 | 0.0% | 1.63% | -13.1% | |
| Buy | BIOHAVEN LTD | $10,223,814 | +86.0% | 427,417 | +6.2% | 1.63% | +30.6% | |
| BMRN | New | BIOMARIN PHARMACEUTICAL INCput | $8,668,000 | – | 100,000 | +100.0% | 1.38% | – |
| CRNX | New | CRINETICS PHARMACEUTICALS IN | $8,559,501 | – | 475,000 | +100.0% | 1.36% | – |
| IMGN | New | IMMUNOGEN INC | $8,448,099 | – | 447,700 | +100.0% | 1.34% | – |
| ACRS | Buy | ACLARIS THERAPEUTICS INCput | $8,257,631 | +39.4% | 796,300 | +8.8% | 1.32% | -2.2% |
| REPL | New | REPLIMUNE GROUP INCput | $8,085,204 | – | 348,200 | +100.0% | 1.29% | – |
| BBIO | Sell | BRIDGEBIO PHARMA INC | $7,390,599 | -25.0% | 429,686 | -27.7% | 1.18% | -47.4% |
| PCVX | Sell | VAXCYTE INC | $6,991,600 | -17.1% | 140,000 | -37.8% | 1.11% | -41.8% |
| New | MARINUS PHARMACEUTICALS INC | $6,645,582 | – | 611,932 | +100.0% | 1.06% | – | |
| IMGN | Buy | IMMUNOGEN INCcall | $6,604,500 | +1513.4% | 350,000 | +228.3% | 1.05% | +1031.2% |
| BMEA | Buy | BIOMEA FUSION INCput | $6,293,065 | +407.3% | 286,700 | +616.8% | 1.00% | +256.6% |
| IMVT | Buy | IMMUNOVANT INCcall | $6,188,014 | +148.9% | 326,200 | +103.5% | 0.98% | +74.6% |
| BMEA | Buy | BIOMEA FUSION INC | $6,055,457 | -7.4% | 275,875 | +30.8% | 0.96% | -35.0% |
| PTGX | PROTAGONIST THERAPEUTICS INCput | $5,838,868 | +20.1% | 211,400 | 0.0% | 0.93% | -15.7% | |
| RCUS | Buy | ARCUS BIOSCIENCES INC | $5,686,800 | +35.6% | 280,000 | +21.7% | 0.91% | -4.8% |
| RARE | New | ULTRAGENYX PHARMACEUTICAL IN | $5,612,084 | – | 121,658 | +100.0% | 0.89% | – |
| PTGX | Sell | PROTAGONIST THERAPEUTICS INCcall | $5,524,000 | +13.6% | 200,000 | -5.4% | 0.88% | -20.2% |
| Buy | BIOHAVEN LTDcall | $5,382,000 | +771.7% | 225,000 | +397.8% | 0.86% | +512.1% | |
| REPL | New | REPLIMUNE GROUP INCcall | $5,301,126 | – | 228,300 | +100.0% | 0.84% | – |
| XENE | Sell | XENON PHARMACEUTICALS INC | $5,216,212 | -9.2% | 135,486 | -15.6% | 0.83% | -36.2% |
| BCYC | Sell | BICYCLE THERAPEUTICS PLCsponsored ads | $5,181,504 | +17.6% | 203,037 | -2.0% | 0.82% | -17.5% |
| Sell | ASTRIA THERAPEUTICS INC | $4,826,318 | -58.3% | 579,390 | -33.4% | 0.77% | -70.7% | |
| LEGN | New | LEGEND BIOTECH CORPcall | $4,749,264 | – | 68,800 | +100.0% | 0.76% | – |
| ARWR | New | ARROWHEAD PHARMACEUTICALS IN | $4,635,800 | – | 130,000 | +100.0% | 0.74% | – |
| INSM | INSMED INCcall | $4,220,000 | +23.8% | 200,000 | 0.0% | 0.67% | -13.2% | |
| RCUS | New | ARCUS BIOSCIENCES INCcall | $4,062,000 | – | 200,000 | +100.0% | 0.65% | – |
| LYRA | Buy | LYRA THERAPEUTICS INC | $4,022,153 | +465.4% | 978,626 | +184.7% | 0.64% | +298.1% |
| LBPH | New | LONGBOARD PHARMACEUTICALS IN | $3,701,216 | – | 504,253 | +100.0% | 0.59% | – |
| VYGR | New | VOYAGER THERAPEUTICS INC | $3,435,000 | – | 300,000 | +100.0% | 0.55% | – |
| ALLK | New | ALLAKOS INC | $3,366,321 | – | 772,092 | +100.0% | 0.54% | – |
| ABOS | Buy | ACUMEN PHARMACEUTICALS INC | $3,150,286 | +204.4% | 654,945 | +156.9% | 0.50% | +113.6% |
| NVAX | New | NOVAVAX INCput | $2,972,000 | – | 400,000 | +100.0% | 0.47% | – |
| NVAX | New | NOVAVAX INCcall | $2,972,000 | – | 400,000 | +100.0% | 0.47% | – |
| TERN | Sell | TERNS PHARMACEUTICALS INC | $2,760,451 | -67.7% | 315,480 | -56.3% | 0.44% | -77.3% |
| BDTX | New | BLACK DIAMOND THERAPEUTICS I | $2,752,770 | – | 545,103 | +100.0% | 0.44% | – |
| BBIO | New | BRIDGEBIO PHARMA INCput | $2,580,000 | – | 150,000 | +100.0% | 0.41% | – |
| SRPT | Sell | SAREPTA THERAPEUTICS INCcall | $2,530,892 | -91.1% | 22,100 | -89.2% | 0.40% | -93.7% |
| DCPH | DECIPHERA PHARMACEUTICALS IN | $2,457,101 | -8.9% | 174,510 | 0.0% | 0.39% | -36.1% | |
| ESPR | Buy | ESPERION THERAPEUTICS INC NE | $2,370,791 | +10.0% | 1,705,605 | +25.8% | 0.38% | -22.7% |
| STOK | New | STOKE THERAPEUTICS INCcall | $2,287,576 | – | 215,200 | +100.0% | 0.36% | – |
| Sell | ROIVANT SCIENCES LTD | $2,267,999 | -46.6% | 225,000 | -60.9% | 0.36% | -62.5% | |
| New | ACELYRIN INCcall | $2,090,000 | – | 100,000 | +100.0% | 0.33% | – | |
| ACRS | Sell | ACLARIS THERAPEUTICS INC | $2,075,690 | -14.5% | 200,163 | -33.3% | 0.33% | -39.9% |
| KZR | KEZAR LIFE SCIENCES INC | $2,061,910 | -21.7% | 841,596 | 0.0% | 0.33% | -45.2% | |
| New | DICE THERAPEUTICS INCput | $2,025,656 | – | 43,600 | +100.0% | 0.32% | – | |
| BIVI | Buy | BIOVIE INCcl a new | $1,933,276 | -31.4% | 448,556 | +28.7% | 0.31% | -51.8% |
| ICPT | Buy | INTERCEPT PHARMACEUTICALS IN | $1,771,813 | +54.8% | 160,200 | +88.0% | 0.28% | +8.5% |
| QURE | New | UNIQURE NVcall | $1,769,424 | – | 154,400 | +100.0% | 0.28% | – |
| TERN | New | TERNS PHARMACEUTICALS INCcall | $1,750,000 | – | 200,000 | +100.0% | 0.28% | – |
| ELEV | New | ELEVATION ONCOLOGY INC | $1,747,225 | – | 1,149,490 | +100.0% | 0.28% | – |
| LEGN | New | LEGEND BIOTECH CORPsponsored ads | $1,725,751 | – | 25,000 | +100.0% | 0.28% | – |
| MRUS | Sell | MERUS N V | $1,662,081 | -56.7% | 63,125 | -69.7% | 0.26% | -69.6% |
| IMUX | IMMUNIC INC | $1,631,500 | +68.5% | 650,000 | 0.0% | 0.26% | +18.2% | |
| Sell | JASPER THERAPEUTICS INC | $1,541,370 | -24.4% | 1,125,087 | -0.1% | 0.24% | -47.1% | |
| SCPH | New | SCPHARMACEUTICALS INC | $1,528,500 | – | 150,000 | +100.0% | 0.24% | – |
| CORBUS PHARMACEUTICALS HLDGS | $1,507,318 | +7.8% | 192,260 | 0.0% | 0.24% | -24.3% | ||
| IMVT | New | IMMUNOVANT INCput | $1,441,720 | – | 76,000 | +100.0% | 0.23% | – |
| BLUE | BLUEBIRD BIO INC | $1,357,545 | +3.5% | 412,628 | 0.0% | 0.22% | -27.5% | |
| MIST | MILESTONE PHARMACEUTICALS IN | $1,312,186 | -27.7% | 460,416 | 0.0% | 0.21% | -49.3% | |
| KALV | KALVISTA PHARMACEUTICALS INC | $1,260,000 | +14.5% | 140,000 | 0.0% | 0.20% | -19.6% | |
| KRYS | KRYSTAL BIOTECH INCput | $1,209,220 | +46.6% | 10,300 | 0.0% | 0.19% | +3.2% | |
| FGEN | New | FIBROGEN INCcall | $1,080,000 | – | 400,000 | +100.0% | 0.17% | – |
| RPHM | RENEO PHARMACEUTICALS INC | $1,022,173 | +9.7% | 155,819 | 0.0% | 0.16% | -22.7% | |
| FGEN | New | FIBROGEN INCput | $1,024,110 | – | 379,300 | +100.0% | 0.16% | – |
| PTGX | New | PROTAGONIST THERAPEUTICS INC | $966,700 | – | 35,000 | +100.0% | 0.15% | – |
| ARDX | Sell | ARDELYX INC | $945,216 | -65.9% | 278,825 | -51.8% | 0.15% | -76.0% |
| TYRA BIOSCIENCES INC | $820,336 | +6.0% | 48,170 | 0.0% | 0.13% | -25.6% | ||
| TCON | TRACON PHARMACEUTICALS INC | $804,769 | -84.6% | 2,765,530 | 0.0% | 0.13% | -89.2% | |
| PRQR | PROQR THRAPEUTICS N V | $765,653 | -23.9% | 472,625 | 0.0% | 0.12% | -46.5% | |
| STOK | New | STOKE THERAPEUTICS INC | $748,245 | – | 70,390 | +100.0% | 0.12% | – |
| COGT | COGENT BIOSCIENCES INC | $743,150 | +9.7% | 62,766 | 0.0% | 0.12% | -23.4% | |
| KPTI | Buy | KARYOPHARM THERAPEUTICS INC | $716,000 | -38.6% | 400,000 | +33.3% | 0.11% | -57.0% |
| XFOR | X4 PHARMACEUTICALS INC | $677,318 | +123.0% | 349,133 | 0.0% | 0.11% | +56.5% | |
| AUTL | AUTOLUS THERAPEUTICS PLCspon ads | $619,006 | +29.3% | 260,087 | 0.0% | 0.10% | -9.2% | |
| FGEN | New | FIBROGEN INC | $616,735 | – | 228,420 | +100.0% | 0.10% | – |
| IMTX | Sell | IMMATICS N.V | $565,817 | +7.5% | 49,031 | -72.7% | 0.09% | -24.4% |
| RETA | Sell | REATA PHARMACEUTICALS INCcl a | $557,925 | -92.4% | 5,472 | -93.2% | 0.09% | -94.6% |
| HOOK | New | HOOKIPA PHARMA INC | $528,000 | – | 600,000 | +100.0% | 0.08% | – |
| OCUL | Sell | OCULAR THERAPEUTIX INC | $516,000 | -51.0% | 100,000 | -50.0% | 0.08% | -65.7% |
| TARA | PROTARA THERAPEUTICS INC | $450,907 | -22.9% | 188,664 | 0.0% | 0.07% | -45.9% | |
| KOD | Sell | KODIAK SCIENCES INC | $431,436 | -57.2% | 62,527 | -61.5% | 0.07% | -69.9% |
| BCLI | BRAINSTORM CELL THERAPEUTICS | $391,266 | -37.6% | 189,935 | 0.0% | 0.06% | -56.3% | |
| MRSN | New | MERSANA THERAPEUTICS INCcall | $363,874 | – | 110,600 | +100.0% | 0.06% | – |
| ANEB | ANEBULO PHARMACEUTICALS INC | $340,523 | -26.4% | 156,203 | 0.0% | 0.05% | -48.6% | |
| MREO | New | MEREO BIOPHARMA GROUP PLCspon ads | $300,235 | – | 891,676 | +100.0% | 0.05% | – |
| ELDN | ELEDON PHARMACEUTICALS INC | $303,908 | -41.9% | 221,830 | 0.0% | 0.05% | -59.7% | |
| CMMB | Sell | CHEMOMAB THERAPEUTICS LTDsponsored ads | $279,543 | -18.3% | 213,392 | -9.9% | 0.04% | -42.3% |
| PNT | Sell | POINT BIOPHARMA GLOBAL INC | $260,783 | -74.3% | 28,784 | -79.4% | 0.04% | -81.7% |
| CNTB | CONNECT BIOPHARMA HLDGS LTDads | $243,645 | +11.0% | 219,501 | 0.0% | 0.04% | -22.0% | |
| VRNA | Buy | VERONA PHARMA PLCsponsored ads | $219,207 | -95.2% | 313,677 | +37.2% | 0.04% | -96.6% |
| New | NUVALENT INCcall | $185,548 | – | 4,400 | +100.0% | 0.03% | – | |
| ASND | New | ASCENDIS PHARMA A/Ssponsored adr | $186,532 | – | 2,090 | +100.0% | 0.03% | – |
| MRSN | New | MERSANA THERAPEUTICS INC | $164,501 | – | 50,000 | +100.0% | 0.03% | – |
| RLMD | RELMADA THERAPEUTICS INC | $161,109 | +8.9% | 65,491 | 0.0% | 0.03% | -23.5% | |
| KDNY | CHINOOK THERAPEUTICS INC | $130,394 | -98.0% | 283,464 | 0.0% | 0.02% | -98.6% | |
| SYBX | SYNLOGIC INC | $131,905 | -32.0% | 306,757 | 0.0% | 0.02% | -52.3% | |
| AVRO | New | AVROBIO INC | $127,453 | – | 134,146 | +100.0% | 0.02% | – |
| FHTX | New | FOGHORN THERAPEUTICS INC | $105,601 | – | 15,000 | +100.0% | 0.02% | – |
| New | FINCH THERAPEUTICS GROUP INC | $67,533 | – | 7,917 | +100.0% | 0.01% | – | |
| ASLAN PHARMACEUTICALS LTDspon ads new | $29,813 | -93.7% | 164,088 | 0.0% | 0.01% | -95.4% | ||
| MDGL | MADRIGAL PHARMACEUTICALS INC | $17,325 | -4.7% | 75 | 0.0% | 0.00% | -25.0% | |
| ERYP | Sell | PHAXIAM THERAPEUTICS S Asponsored adr | $2,257 | -99.1% | 3,019 | -98.8% | 0.00% | -100.0% |
| CYCC | Exit | CYCLACEL PHARMACEUTICALS INC | $0 | – | -275,000 | -100.0% | -0.00% | – |
| GOSS | Exit | GOSSAMER BIO INC | $0 | – | -6,100 | -100.0% | -0.00% | – |
| Exit | ROCKET PHARMACEUTICALS INC*w exp 09/02/202 | $0 | – | -367,112 | -100.0% | -0.01% | – | |
| FNCH | Exit | FINCH THERAPEUTICS GROUP INC | $0 | – | -237,553 | -100.0% | -0.02% | – |
| STSA | Exit | SATSUMA PHARMACEUTICALS INC | $0 | – | -136,059 | -100.0% | -0.02% | – |
| SPPI | Exit | SPECTRUM PHARMACEUTICALS INC | $0 | – | -176,980 | -100.0% | -0.03% | – |
| GNFT | Exit | GENFIT S Aads | $0 | – | -32,786 | -100.0% | -0.03% | – |
| Exit | BELLICUM PHARMACEUTICALS INC | $0 | – | -448,101 | -100.0% | -0.03% | – | |
| ARKK | Exit | ARK ETF TRinnovation etf | $0 | – | -4,519 | -100.0% | -0.04% | – |
| BIIB | Exit | BIOGEN INC | $0 | – | -962 | -100.0% | -0.06% | – |
| Exit | AMYLYX PHARMACEUTICALS INC | $0 | – | -10,000 | -100.0% | -0.07% | – | |
| PTCT | Exit | PTC THERAPEUTICS INCcall | $0 | – | -9,800 | -100.0% | -0.11% | – |
| VKTX | Exit | VIKING THERAPEUTICS INC | $0 | – | -43,156 | -100.0% | -0.16% | – |
| SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -17,805 | -100.0% | -0.17% | – |
| Exit | ACHIEVE LIFE SCIENCES INC | $0 | – | -174,714 | -100.0% | -0.22% | – | |
| IVA | Exit | INVENTIVA SAads | $0 | – | -292,599 | -100.0% | -0.23% | – |
| DCTH | Exit | DELCATH SYS INC | $0 | – | -360,569 | -100.0% | -0.24% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -60,000 | -100.0% | -0.26% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -8,324 | -100.0% | -0.26% | – |
| MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -33,100 | -100.0% | -0.28% | – |
| BTAI | Exit | BIOXCEL THERAPEUTICS INCcall | $0 | – | -71,200 | -100.0% | -0.30% | – |
| ARKG | Exit | ARK ETF TRgenomic rev etf | $0 | – | -46,462 | -100.0% | -0.32% | – |
| MORF | Exit | MORPHIC HLDG INC | $0 | – | -45,873 | -100.0% | -0.39% | – |
| MGNX | Exit | MACROGENICS INC | $0 | – | -250,000 | -100.0% | -0.41% | – |
| AKRO | Exit | AKERO THERAPEUTICS INC | $0 | – | -50,000 | -100.0% | -0.43% | – |
| CYTK | Exit | CYTOKINETICS INC | $0 | – | -55,666 | -100.0% | -0.44% | – |
| Exit | VENTYX BIOSCIENCES INC | $0 | – | -65,000 | -100.0% | -0.49% | – | |
| BTAI | Exit | BIOXCEL THERAPEUTICS INC | $0 | – | -133,014 | -100.0% | -0.56% | – |
| ALT | Exit | ALTIMMUNE INC | $0 | – | -677,300 | -100.0% | -0.65% | – |
| XLV | Exit | SELECT SECTOR SPDR TRsbi healthcare | $0 | – | -27,469 | -100.0% | -0.81% | – |
| ALT | Exit | ALTIMMUNE INCcall | $0 | – | -898,600 | -100.0% | -0.86% | – |
| CLDX | Exit | CELLDEX THERAPEUTICS INC NEW | $0 | – | -106,057 | -100.0% | -0.87% | – |
| AVTE | Exit | AEROVATE THERAPEUTICS INC | $0 | – | -195,146 | -100.0% | -0.89% | – |
| CLDX | Exit | CELLDEX THERAPEUTICS INC NEWput | $0 | – | -110,000 | -100.0% | -0.90% | – |
| BCYC | Exit | BICYCLE THERAPEUTICS PLCcall | $0 | – | -200,000 | -100.0% | -0.96% | – |
| Exit | AMYLYX PHARMACEUTICALS INCcall | $0 | – | -150,000 | -100.0% | -1.00% | – | |
| ALT | Exit | ALTIMMUNE INCput | $0 | – | -1,077,200 | -100.0% | -1.03% | – |
| ACRS | Exit | ACLARIS THERAPEUTICS INCcall | $0 | – | -589,300 | -100.0% | -1.08% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -50,000 | -100.0% | -1.10% | – |
| ISEE | Exit | IVERIC BIO INC | $0 | – | -213,521 | -100.0% | -1.18% | – |
| BLU | Exit | BELLUS HEALTH INC NEW | $0 | – | -885,334 | -100.0% | -1.45% | – |
| XBI | Exit | SPDR SER TRput | $0 | – | -100,000 | -100.0% | -1.73% | – |
| MORF | Exit | MORPHIC HLDG INCcall | $0 | – | -213,400 | -100.0% | -1.82% | – |
| AXSM | Exit | AXSOME THERAPEUTICS INCcall | $0 | – | -150,000 | -100.0% | -2.10% | – |
| AXSM | Exit | AXSOME THERAPEUTICS INCput | $0 | – | -150,000 | -100.0% | -2.10% | – |
| IMVT | Exit | IMMUNOVANT INC | $0 | – | -774,398 | -100.0% | -2.72% | – |
| RXDX | Exit | PROMETHEUS BIOSCIENCES INC | $0 | – | -125,926 | -100.0% | -3.07% | – |
| ITCI | Exit | INTRA-CELLULAR THERAPIES INCcall | $0 | – | -380,000 | -100.0% | -4.67% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| XENON PHARMACEUTICALS INC | 15 | Q2 2023 | 1.5% |
| OCULAR THERAPEUTIX INC | 15 | Q3 2023 | 1.4% |
| SAREPTA THERAPEUTICS INC | 14 | Q3 2023 | 6.4% |
| X4 PHARMACEUTICALS INC - PIPE | 14 | Q2 2023 | 1.4% |
| PROTARA THERAPEUTICS INC | 14 | Q3 2023 | 1.2% |
| SPDR SER TR | 13 | Q3 2023 | 9.0% |
| VAXCYTE INC | 13 | Q3 2023 | 2.9% |
| TRACON PHARMACEUTICALS INC | 13 | Q3 2023 | 1.4% |
| MILESTONE PHARMACEUTICALS IN | 13 | Q3 2023 | 1.7% |
| BELLUS HEALTH INC NEW | 13 | Q1 2023 | 1.8% |
View Ikarian Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Milestone Pharmaceuticals Inc. | February 14, 2023 | 460,416 | 1.3% |
| X4 Pharmaceuticals, Inc | February 14, 2023 | 349,133 | 0.3% |
| aTYR PHARMA INC | February 14, 2022 | 35,048 | 0.1% |
| Cyclacel Pharmaceuticals, Inc. | February 14, 2022 | 99,422 | 1.0% |
| KalVista Pharmaceuticals, Inc. | February 14, 2022 | 36,576 | 0.2% |
| Lyra Therapeutics, Inc. | February 14, 2022 | 394,536 | 3.0% |
| Odonate Therapeutics, Inc. | February 14, 2022 | 1,340,631 | 3.5% |
| Protara Therapeutics, Inc. | February 14, 2022 | 279,256 | 2.5% |
| Science 37 Holdings, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| scPharmaceuticals Inc. | February 14, 2022 | 901,362 | 3.3% |
View Ikarian Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-04-05 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
View Ikarian Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.